["{\n\"step_by_step_thinking\": \"The relevant documents provide information about patient resistance and prognosis in amyotrophic lateral sclerosis. The studies show that many patients live for longer than 5 years and may have remissions of their illness. Additionally, immunological studies did not reveal any well-defined deviations from reference intervals or characteristic features depending on the patients' clinical status. There is no indication that ozanezumab has been studied or found to be effective in treating amyotrophic lateral sclerosis.\",\n\"answer_choice\": \"B: no\"\n}"]